IndraLab

Statements


| 1

sparser
"Some strategies such as inhibition of cyclin-dependent kinase 4/6 (CDK4/6) by palbociclib and inhibition of CSN5 by curcumin or berberine were designed to enhance antitumor immunity [ xref ]."
| PMC